nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP2C9—brain cancer	0.632	1	CbGaD
Gemfibrozil—CYP1A2—Carmustine—brain cancer	0.0746	0.309	CbGbCtD
Gemfibrozil—CYP3A4—Temozolomide—brain cancer	0.0564	0.234	CbGbCtD
Gemfibrozil—CYP3A4—Lomustine—brain cancer	0.0479	0.199	CbGbCtD
Gemfibrozil—CYP2C8—Etoposide—brain cancer	0.0286	0.118	CbGbCtD
Gemfibrozil—CYP1A2—Etoposide—brain cancer	0.0221	0.0917	CbGbCtD
Gemfibrozil—CYP3A4—Etoposide—brain cancer	0.0116	0.048	CbGbCtD
Gemfibrozil—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00198	0.0518	CbGpPWpGaD
Gemfibrozil—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00178	0.0466	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00172	0.0451	CbGpPWpGaD
Gemfibrozil—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00162	0.0424	CbGpPWpGaD
Gemfibrozil—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00159	0.0416	CbGpPWpGaD
Gemfibrozil—Bone marrow depression—Hydroxyurea—brain cancer	0.00153	0.0172	CcSEcCtD
Gemfibrozil—Cerebral haemorrhage—Carmustine—brain cancer	0.00151	0.017	CcSEcCtD
Gemfibrozil—Cerebral haemorrhage—Temozolomide—brain cancer	0.00146	0.0164	CcSEcCtD
Gemfibrozil—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00144	0.0378	CbGpPWpGaD
Gemfibrozil—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00138	0.0361	CbGpPWpGaD
Gemfibrozil—Myasthenia—Carmustine—brain cancer	0.00133	0.0149	CcSEcCtD
Gemfibrozil—Pancytopenia—Lomustine—brain cancer	0.00125	0.0141	CcSEcCtD
Gemfibrozil—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00124	0.0324	CbGpPWpGaD
Gemfibrozil—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00123	0.0322	CbGpPWpGaD
Gemfibrozil—PPARA—SREBF and miR33 in cholesterol and lipid homeostasis—SIRT1—brain cancer	0.00117	0.0307	CbGpPWpGaD
Gemfibrozil—Renal failure—Lomustine—brain cancer	0.00116	0.013	CcSEcCtD
Gemfibrozil—Myopathy—Temozolomide—brain cancer	0.00115	0.0129	CcSEcCtD
Gemfibrozil—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00112	0.0295	CbGpPWpGaD
Gemfibrozil—Photosensitivity—Procarbazine—brain cancer	0.0011	0.0124	CcSEcCtD
Gemfibrozil—Hyperaesthesia—Temozolomide—brain cancer	0.00103	0.0116	CcSEcCtD
Gemfibrozil—Alopecia—Lomustine—brain cancer	0.000934	0.0105	CcSEcCtD
Gemfibrozil—Drug interaction—Carmustine—brain cancer	0.000901	0.0101	CcSEcCtD
Gemfibrozil—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000853	0.0224	CbGpPWpGaD
Gemfibrozil—PPARA—Orphan transporters—S100A10—brain cancer	0.000849	0.0223	CbGpPWpGaD
Gemfibrozil—Eosinophilia—Procarbazine—brain cancer	0.00083	0.00933	CcSEcCtD
Gemfibrozil—Leukopenia—Lomustine—brain cancer	0.000824	0.00926	CcSEcCtD
Gemfibrozil—Pancreatitis—Procarbazine—brain cancer	0.000822	0.00924	CcSEcCtD
Gemfibrozil—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000821	0.0215	CbGpPWpGaD
Gemfibrozil—Musculoskeletal pain—Temozolomide—brain cancer	0.000818	0.00919	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Temozolomide—brain cancer	0.000808	0.00908	CcSEcCtD
Gemfibrozil—Pancytopenia—Procarbazine—brain cancer	0.000796	0.00895	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Procarbazine—brain cancer	0.000765	0.0086	CcSEcCtD
Gemfibrozil—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000762	0.02	CbGpPWpGaD
Gemfibrozil—Thrombocytopenia—Lomustine—brain cancer	0.000735	0.00826	CcSEcCtD
Gemfibrozil—Pain—Carboplatin—brain cancer	0.000734	0.00825	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Procarbazine—brain cancer	0.000733	0.00824	CcSEcCtD
Gemfibrozil—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000732	0.0192	CbGpPWpGaD
Gemfibrozil—Jaundice—Procarbazine—brain cancer	0.000729	0.00819	CcSEcCtD
Gemfibrozil—PPARA—Nuclear Receptors—ESR2—brain cancer	0.000728	0.0191	CbGpPWpGaD
Gemfibrozil—Breast disorder—Hydroxyurea—brain cancer	0.000678	0.00762	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.000674	0.00758	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Etoposide—brain cancer	0.000647	0.00727	CcSEcCtD
Gemfibrozil—Pancreatitis—Hydroxyurea—brain cancer	0.000636	0.00715	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Temozolomide—brain cancer	0.000622	0.00699	CcSEcCtD
Gemfibrozil—Pancytopenia—Hydroxyurea—brain cancer	0.000616	0.00693	CcSEcCtD
Gemfibrozil—PPARA—PPAR Alpha Pathway—CDK4—brain cancer	0.000601	0.0157	CbGpPWpGaD
Gemfibrozil—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000593	0.0156	CbGpPWpGaD
Gemfibrozil—Alopecia—Procarbazine—brain cancer	0.000593	0.00666	CcSEcCtD
Gemfibrozil—PPARA—Estrogen Receptor Pathway—STAT3—brain cancer	0.000583	0.0153	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000575	0.0151	CbGpPWpGaD
Gemfibrozil—Tension—Procarbazine—brain cancer	0.000573	0.00644	CcSEcCtD
Gemfibrozil—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000571	0.015	CbGpPWpGaD
Gemfibrozil—Nervousness—Procarbazine—brain cancer	0.000567	0.00638	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000567	0.00637	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Carmustine—brain cancer	0.00056	0.0063	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000547	0.00615	CcSEcCtD
Gemfibrozil—Anaemia—Procarbazine—brain cancer	0.00054	0.00607	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.00054	0.00606	CcSEcCtD
Gemfibrozil—Muscular weakness—Carmustine—brain cancer	0.000535	0.00602	CcSEcCtD
Gemfibrozil—Breast disorder—Temozolomide—brain cancer	0.00053	0.00596	CcSEcCtD
Gemfibrozil—Syncope—Procarbazine—brain cancer	0.000524	0.00589	CcSEcCtD
Gemfibrozil—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.000524	0.0137	CbGpPWpGaD
Gemfibrozil—Leukopenia—Procarbazine—brain cancer	0.000523	0.00588	CcSEcCtD
Gemfibrozil—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000523	0.0137	CbGpPWpGaD
Gemfibrozil—Muscular weakness—Temozolomide—brain cancer	0.000517	0.00581	CcSEcCtD
Gemfibrozil—Loss of consciousness—Procarbazine—brain cancer	0.000514	0.00577	CcSEcCtD
Gemfibrozil—Cough—Procarbazine—brain cancer	0.00051	0.00573	CcSEcCtD
Gemfibrozil—Convulsion—Procarbazine—brain cancer	0.000506	0.00569	CcSEcCtD
Gemfibrozil—Pancytopenia—Carmustine—brain cancer	0.000498	0.0056	CcSEcCtD
Gemfibrozil—Arthralgia—Procarbazine—brain cancer	0.000497	0.00559	CcSEcCtD
Gemfibrozil—Myalgia—Procarbazine—brain cancer	0.000497	0.00559	CcSEcCtD
Gemfibrozil—Pancytopenia—Temozolomide—brain cancer	0.000481	0.00541	CcSEcCtD
Gemfibrozil—Confusional state—Procarbazine—brain cancer	0.000481	0.0054	CcSEcCtD
Gemfibrozil—Vomiting—Lomustine—brain cancer	0.000478	0.00537	CcSEcCtD
Gemfibrozil—Oedema—Procarbazine—brain cancer	0.000477	0.00536	CcSEcCtD
Gemfibrozil—Shock—Procarbazine—brain cancer	0.000469	0.00527	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Temozolomide—brain cancer	0.000467	0.00525	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Procarbazine—brain cancer	0.000467	0.00525	CcSEcCtD
Gemfibrozil—Depression—Carmustine—brain cancer	0.000466	0.00524	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—NTRK3—brain cancer	0.000466	0.0122	CbGpPWpGaD
Gemfibrozil—Photosensitivity reaction—Temozolomide—brain cancer	0.000463	0.0052	CcSEcCtD
Gemfibrozil—Renal failure—Carmustine—brain cancer	0.00046	0.00517	CcSEcCtD
Gemfibrozil—Alopecia—Hydroxyurea—brain cancer	0.000459	0.00516	CcSEcCtD
Gemfibrozil—Weight decreased—Temozolomide—brain cancer	0.000459	0.00515	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Carmustine—brain cancer	0.000458	0.00515	CcSEcCtD
Gemfibrozil—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000458	0.012	CbGpPWpGaD
Gemfibrozil—Urinary tract infection—Carmustine—brain cancer	0.000455	0.00511	CcSEcCtD
Gemfibrozil—Depression—Temozolomide—brain cancer	0.000451	0.00507	CcSEcCtD
Gemfibrozil—Nausea—Lomustine—brain cancer	0.000446	0.00501	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Temozolomide—brain cancer	0.000443	0.00498	CcSEcCtD
Gemfibrozil—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00044	0.0115	CbGpPWpGaD
Gemfibrozil—Urinary tract infection—Temozolomide—brain cancer	0.000439	0.00494	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000434	0.00488	CcSEcCtD
Gemfibrozil—Paraesthesia—Procarbazine—brain cancer	0.000428	0.00481	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Temozolomide—brain cancer	0.000427	0.0048	CcSEcCtD
Gemfibrozil—Somnolence—Procarbazine—brain cancer	0.000424	0.00476	CcSEcCtD
Gemfibrozil—Anaemia—Hydroxyurea—brain cancer	0.000418	0.0047	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Carmustine—brain cancer	0.000418	0.0047	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Carmustine—brain cancer	0.000413	0.00464	CcSEcCtD
Gemfibrozil—Fatigue—Procarbazine—brain cancer	0.000411	0.00462	CcSEcCtD
Gemfibrozil—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00041	0.0107	CbGpPWpGaD
Gemfibrozil—Pain—Procarbazine—brain cancer	0.000408	0.00458	CcSEcCtD
Gemfibrozil—Constipation—Procarbazine—brain cancer	0.000408	0.00458	CcSEcCtD
Gemfibrozil—Leukopenia—Hydroxyurea—brain cancer	0.000405	0.00455	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Temozolomide—brain cancer	0.000404	0.00454	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Temozolomide—brain cancer	0.000399	0.00448	CcSEcCtD
Gemfibrozil—Feeling abnormal—Procarbazine—brain cancer	0.000393	0.00442	CcSEcCtD
Gemfibrozil—Eye disorder—Carmustine—brain cancer	0.000392	0.00441	CcSEcCtD
Gemfibrozil—Convulsion—Hydroxyurea—brain cancer	0.000392	0.0044	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Procarbazine—brain cancer	0.00039	0.00438	CcSEcCtD
Gemfibrozil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000388	0.0102	CbGpPWpGaD
Gemfibrozil—PPARA—PPAR Alpha Pathway—CCND1—brain cancer	0.000388	0.0102	CbGpPWpGaD
Gemfibrozil—Pancytopenia—Etoposide—brain cancer	0.000385	0.00433	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000382	0.0043	CcSEcCtD
Gemfibrozil—Eye disorder—Temozolomide—brain cancer	0.000379	0.00426	CcSEcCtD
Gemfibrozil—Urticaria—Procarbazine—brain cancer	0.000379	0.00426	CcSEcCtD
Gemfibrozil—Abdominal pain—Procarbazine—brain cancer	0.000377	0.00424	CcSEcCtD
Gemfibrozil—Alopecia—Carmustine—brain cancer	0.000371	0.00417	CcSEcCtD
Gemfibrozil—Oedema—Hydroxyurea—brain cancer	0.000369	0.00415	CcSEcCtD
Gemfibrozil—Mental disorder—Carmustine—brain cancer	0.000368	0.00413	CcSEcCtD
Gemfibrozil—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000366	0.00959	CbGpPWpGaD
Gemfibrozil—Mediastinal disorder—Temozolomide—brain cancer	0.000366	0.00411	CcSEcCtD
Gemfibrozil—Nervous system disorder—Hydroxyurea—brain cancer	0.000362	0.00407	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Hydroxyurea—brain cancer	0.000361	0.00406	CcSEcCtD
Gemfibrozil—Alopecia—Temozolomide—brain cancer	0.000359	0.00403	CcSEcCtD
Gemfibrozil—Skin disorder—Hydroxyurea—brain cancer	0.000358	0.00403	CcSEcCtD
Gemfibrozil—Renal failure—Etoposide—brain cancer	0.000356	0.004	CcSEcCtD
Gemfibrozil—Mental disorder—Temozolomide—brain cancer	0.000355	0.004	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Etoposide—brain cancer	0.000355	0.00398	CcSEcCtD
Gemfibrozil—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000354	0.00929	CbGpPWpGaD
Gemfibrozil—Jaundice—Etoposide—brain cancer	0.000353	0.00396	CcSEcCtD
Gemfibrozil—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00035	0.00917	CbGpPWpGaD
Gemfibrozil—Dysgeusia—Temozolomide—brain cancer	0.000346	0.00389	CcSEcCtD
Gemfibrozil—Vision blurred—Carmustine—brain cancer	0.000344	0.00387	CcSEcCtD
Gemfibrozil—Asthenia—Procarbazine—brain cancer	0.000342	0.00384	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Etoposide—brain cancer	0.000342	0.00384	CcSEcCtD
Gemfibrozil—Anaemia—Carmustine—brain cancer	0.000338	0.0038	CcSEcCtD
Gemfibrozil—Pruritus—Procarbazine—brain cancer	0.000337	0.00379	CcSEcCtD
Gemfibrozil—Vision blurred—Temozolomide—brain cancer	0.000333	0.00374	CcSEcCtD
Gemfibrozil—Somnolence—Hydroxyurea—brain cancer	0.000328	0.00369	CcSEcCtD
Gemfibrozil—Leukopenia—Carmustine—brain cancer	0.000327	0.00368	CcSEcCtD
Gemfibrozil—Anaemia—Temozolomide—brain cancer	0.000326	0.00367	CcSEcCtD
Gemfibrozil—Diarrhoea—Procarbazine—brain cancer	0.000326	0.00367	CcSEcCtD
Gemfibrozil—Dyspepsia—Hydroxyurea—brain cancer	0.000325	0.00365	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Etoposide—brain cancer	0.000323	0.00363	CcSEcCtD
Gemfibrozil—Angioedema—Temozolomide—brain cancer	0.000323	0.00363	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000319	0.00358	CcSEcCtD
Gemfibrozil—Fatigue—Hydroxyurea—brain cancer	0.000318	0.00358	CcSEcCtD
Gemfibrozil—Vertigo—Temozolomide—brain cancer	0.000317	0.00357	CcSEcCtD
Gemfibrozil—Convulsion—Carmustine—brain cancer	0.000317	0.00356	CcSEcCtD
Gemfibrozil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000316	0.00829	CbGpPWpGaD
Gemfibrozil—Leukopenia—Temozolomide—brain cancer	0.000316	0.00355	CcSEcCtD
Gemfibrozil—Pain—Hydroxyurea—brain cancer	0.000316	0.00355	CcSEcCtD
Gemfibrozil—Constipation—Hydroxyurea—brain cancer	0.000316	0.00355	CcSEcCtD
Gemfibrozil—Dizziness—Procarbazine—brain cancer	0.000315	0.00354	CcSEcCtD
Gemfibrozil—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000314	0.00824	CbGpPWpGaD
Gemfibrozil—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000312	0.00818	CbGpPWpGaD
Gemfibrozil—Chest pain—Carmustine—brain cancer	0.000311	0.0035	CcSEcCtD
Gemfibrozil—Myalgia—Carmustine—brain cancer	0.000311	0.0035	CcSEcCtD
Gemfibrozil—PPARA—PPAR Alpha Pathway—MYC—brain cancer	0.000311	0.00816	CbGpPWpGaD
Gemfibrozil—Cough—Temozolomide—brain cancer	0.000308	0.00346	CcSEcCtD
Gemfibrozil—Convulsion—Temozolomide—brain cancer	0.000306	0.00344	CcSEcCtD
Gemfibrozil—Feeling abnormal—Hydroxyurea—brain cancer	0.000304	0.00342	CcSEcCtD
Gemfibrozil—Eye disorder—Etoposide—brain cancer	0.000303	0.00341	CcSEcCtD
Gemfibrozil—Vomiting—Procarbazine—brain cancer	0.000303	0.00341	CcSEcCtD
Gemfibrozil—Confusional state—Carmustine—brain cancer	0.000301	0.00338	CcSEcCtD
Gemfibrozil—Myalgia—Temozolomide—brain cancer	0.000301	0.00338	CcSEcCtD
Gemfibrozil—Arthralgia—Temozolomide—brain cancer	0.000301	0.00338	CcSEcCtD
Gemfibrozil—Rash—Procarbazine—brain cancer	0.000301	0.00338	CcSEcCtD
Gemfibrozil—Dermatitis—Procarbazine—brain cancer	0.0003	0.00338	CcSEcCtD
Gemfibrozil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.0003	0.00785	CbGpPWpGaD
Gemfibrozil—Headache—Procarbazine—brain cancer	0.000299	0.00336	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000299	0.00336	CcSEcCtD
Gemfibrozil—Oedema—Carmustine—brain cancer	0.000298	0.00335	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Etoposide—brain cancer	0.000293	0.00329	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Carmustine—brain cancer	0.000292	0.00328	CcSEcCtD
Gemfibrozil—Confusional state—Temozolomide—brain cancer	0.000291	0.00327	CcSEcCtD
Gemfibrozil—Oedema—Temozolomide—brain cancer	0.000288	0.00324	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Temozolomide—brain cancer	0.000288	0.00324	CcSEcCtD
Gemfibrozil—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000287	0.00753	CbGpPWpGaD
Gemfibrozil—Alopecia—Etoposide—brain cancer	0.000287	0.00322	CcSEcCtD
Gemfibrozil—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000285	0.00747	CbGpPWpGaD
Gemfibrozil—Nausea—Procarbazine—brain cancer	0.000283	0.00318	CcSEcCtD
Gemfibrozil—Nervous system disorder—Temozolomide—brain cancer	0.000283	0.00318	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Temozolomide—brain cancer	0.000282	0.00317	CcSEcCtD
Gemfibrozil—Skin disorder—Temozolomide—brain cancer	0.00028	0.00315	CcSEcCtD
Gemfibrozil—Dysgeusia—Etoposide—brain cancer	0.000277	0.00311	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Carmustine—brain cancer	0.000272	0.00305	CcSEcCtD
Gemfibrozil—Paraesthesia—Carmustine—brain cancer	0.000268	0.00301	CcSEcCtD
Gemfibrozil—Somnolence—Carmustine—brain cancer	0.000265	0.00298	CcSEcCtD
Gemfibrozil—Asthenia—Hydroxyurea—brain cancer	0.000265	0.00298	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000263	0.00295	CcSEcCtD
Gemfibrozil—Anaemia—Etoposide—brain cancer	0.000261	0.00294	CcSEcCtD
Gemfibrozil—Paraesthesia—Temozolomide—brain cancer	0.000259	0.00291	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Carmustine—brain cancer	0.000258	0.00289	CcSEcCtD
Gemfibrozil—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000256	0.00672	CbGpPWpGaD
Gemfibrozil—Somnolence—Temozolomide—brain cancer	0.000256	0.00288	CcSEcCtD
Gemfibrozil—Pain—Carmustine—brain cancer	0.000255	0.00287	CcSEcCtD
Gemfibrozil—Constipation—Carmustine—brain cancer	0.000255	0.00287	CcSEcCtD
Gemfibrozil—Vertigo—Etoposide—brain cancer	0.000254	0.00285	CcSEcCtD
Gemfibrozil—Dyspepsia—Temozolomide—brain cancer	0.000254	0.00285	CcSEcCtD
Gemfibrozil—Leukopenia—Etoposide—brain cancer	0.000253	0.00284	CcSEcCtD
Gemfibrozil—Diarrhoea—Hydroxyurea—brain cancer	0.000252	0.00284	CcSEcCtD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—CDK4—brain cancer	0.000252	0.00661	CbGpPWpGaD
Gemfibrozil—Gastrointestinal disorder—Temozolomide—brain cancer	0.000249	0.0028	CcSEcCtD
Gemfibrozil—Fatigue—Temozolomide—brain cancer	0.000249	0.00279	CcSEcCtD
Gemfibrozil—Loss of consciousness—Etoposide—brain cancer	0.000248	0.00279	CcSEcCtD
Gemfibrozil—Cough—Etoposide—brain cancer	0.000247	0.00277	CcSEcCtD
Gemfibrozil—Constipation—Temozolomide—brain cancer	0.000247	0.00277	CcSEcCtD
Gemfibrozil—Pain—Temozolomide—brain cancer	0.000247	0.00277	CcSEcCtD
Gemfibrozil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000246	0.00646	CbGpPWpGaD
Gemfibrozil—Feeling abnormal—Carmustine—brain cancer	0.000246	0.00276	CcSEcCtD
Gemfibrozil—Convulsion—Etoposide—brain cancer	0.000245	0.00275	CcSEcCtD
Gemfibrozil—Dizziness—Hydroxyurea—brain cancer	0.000244	0.00274	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Carmustine—brain cancer	0.000244	0.00274	CcSEcCtD
Gemfibrozil—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000243	0.00637	CbGpPWpGaD
Gemfibrozil—Chest pain—Etoposide—brain cancer	0.000241	0.0027	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000239	0.00269	CcSEcCtD
Gemfibrozil—Feeling abnormal—Temozolomide—brain cancer	0.000238	0.00267	CcSEcCtD
Gemfibrozil—Abdominal pain—Carmustine—brain cancer	0.000236	0.00265	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Temozolomide—brain cancer	0.000236	0.00265	CcSEcCtD
Gemfibrozil—Vomiting—Hydroxyurea—brain cancer	0.000235	0.00264	CcSEcCtD
Gemfibrozil—Rash—Hydroxyurea—brain cancer	0.000233	0.00261	CcSEcCtD
Gemfibrozil—Confusional state—Etoposide—brain cancer	0.000233	0.00261	CcSEcCtD
Gemfibrozil—Dermatitis—Hydroxyurea—brain cancer	0.000232	0.00261	CcSEcCtD
Gemfibrozil—Headache—Hydroxyurea—brain cancer	0.000231	0.0026	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Etoposide—brain cancer	0.000231	0.00259	CcSEcCtD
Gemfibrozil—Urticaria—Temozolomide—brain cancer	0.000229	0.00257	CcSEcCtD
Gemfibrozil—Abdominal pain—Temozolomide—brain cancer	0.000228	0.00256	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Etoposide—brain cancer	0.000226	0.00254	CcSEcCtD
Gemfibrozil—Skin disorder—Etoposide—brain cancer	0.000224	0.00252	CcSEcCtD
Gemfibrozil—Nausea—Hydroxyurea—brain cancer	0.000219	0.00246	CcSEcCtD
Gemfibrozil—Asthenia—Carmustine—brain cancer	0.000214	0.00241	CcSEcCtD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—S100A10—brain cancer	0.000207	0.00543	CbGpPWpGaD
Gemfibrozil—Paraesthesia—Etoposide—brain cancer	0.000207	0.00233	CcSEcCtD
Gemfibrozil—Asthenia—Temozolomide—brain cancer	0.000207	0.00232	CcSEcCtD
Gemfibrozil—Somnolence—Etoposide—brain cancer	0.000205	0.0023	CcSEcCtD
Gemfibrozil—Diarrhoea—Carmustine—brain cancer	0.000204	0.00229	CcSEcCtD
Gemfibrozil—Pruritus—Temozolomide—brain cancer	0.000204	0.00229	CcSEcCtD
Gemfibrozil—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.0002	0.00524	CbGpPWpGaD
Gemfibrozil—Gastrointestinal disorder—Etoposide—brain cancer	0.000199	0.00224	CcSEcCtD
Gemfibrozil—Fatigue—Etoposide—brain cancer	0.000199	0.00224	CcSEcCtD
Gemfibrozil—Dizziness—Carmustine—brain cancer	0.000197	0.00222	CcSEcCtD
Gemfibrozil—Pain—Etoposide—brain cancer	0.000197	0.00222	CcSEcCtD
Gemfibrozil—Constipation—Etoposide—brain cancer	0.000197	0.00222	CcSEcCtD
Gemfibrozil—Diarrhoea—Temozolomide—brain cancer	0.000197	0.00222	CcSEcCtD
Gemfibrozil—Dizziness—Temozolomide—brain cancer	0.000191	0.00214	CcSEcCtD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00019	0.00498	CbGpPWpGaD
Gemfibrozil—Feeling abnormal—Etoposide—brain cancer	0.00019	0.00214	CcSEcCtD
Gemfibrozil—Vomiting—Carmustine—brain cancer	0.00019	0.00213	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Etoposide—brain cancer	0.000189	0.00212	CcSEcCtD
Gemfibrozil—Rash—Carmustine—brain cancer	0.000188	0.00211	CcSEcCtD
Gemfibrozil—Dermatitis—Carmustine—brain cancer	0.000188	0.00211	CcSEcCtD
Gemfibrozil—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000188	0.00492	CbGpPWpGaD
Gemfibrozil—Headache—Carmustine—brain cancer	0.000187	0.0021	CcSEcCtD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—RELA—brain cancer	0.000185	0.00486	CbGpPWpGaD
Gemfibrozil—Vomiting—Temozolomide—brain cancer	0.000183	0.00206	CcSEcCtD
Gemfibrozil—Urticaria—Etoposide—brain cancer	0.000183	0.00206	CcSEcCtD
Gemfibrozil—Abdominal pain—Etoposide—brain cancer	0.000182	0.00205	CcSEcCtD
Gemfibrozil—Rash—Temozolomide—brain cancer	0.000182	0.00204	CcSEcCtD
Gemfibrozil—Dermatitis—Temozolomide—brain cancer	0.000182	0.00204	CcSEcCtD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000181	0.00474	CbGpPWpGaD
Gemfibrozil—Headache—Temozolomide—brain cancer	0.000181	0.00203	CcSEcCtD
Gemfibrozil—Nausea—Carmustine—brain cancer	0.000177	0.00199	CcSEcCtD
Gemfibrozil—PPARA—Adipogenesis—IRS2—brain cancer	0.000177	0.00463	CbGpPWpGaD
Gemfibrozil—Nausea—Temozolomide—brain cancer	0.000171	0.00192	CcSEcCtD
Gemfibrozil—Asthenia—Etoposide—brain cancer	0.000166	0.00186	CcSEcCtD
Gemfibrozil—Pruritus—Etoposide—brain cancer	0.000163	0.00183	CcSEcCtD
Gemfibrozil—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000162	0.00423	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Etoposide—brain cancer	0.000158	0.00177	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—SIRT1—brain cancer	0.000155	0.00406	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000154	0.00404	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000153	0.004	CbGpPWpGaD
Gemfibrozil—Dizziness—Etoposide—brain cancer	0.000153	0.00171	CcSEcCtD
Gemfibrozil—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.00015	0.00394	CbGpPWpGaD
Gemfibrozil—Vomiting—Etoposide—brain cancer	0.000147	0.00165	CcSEcCtD
Gemfibrozil—Rash—Etoposide—brain cancer	0.000145	0.00163	CcSEcCtD
Gemfibrozil—Dermatitis—Etoposide—brain cancer	0.000145	0.00163	CcSEcCtD
Gemfibrozil—Headache—Etoposide—brain cancer	0.000145	0.00162	CcSEcCtD
Gemfibrozil—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000143	0.00375	CbGpPWpGaD
Gemfibrozil—Nausea—Etoposide—brain cancer	0.000137	0.00154	CcSEcCtD
Gemfibrozil—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000136	0.00357	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000134	0.00352	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000132	0.00346	CbGpPWpGaD
Gemfibrozil—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000132	0.00345	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000117	0.00307	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—CDK4—brain cancer	0.000117	0.00307	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TRPC6—brain cancer	0.000113	0.00296	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000109	0.00287	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000106	0.00278	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—CTNNB1—brain cancer	0.000106	0.00278	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000105	0.00274	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000102	0.00267	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—ESR2—brain cancer	9.94e-05	0.00261	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—TRPC6—brain cancer	9.57e-05	0.00251	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—NOTCH2—brain cancer	9.41e-05	0.00247	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—STAT3—brain cancer	9.24e-05	0.00242	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP2C9—brain cancer	8.19e-05	0.00215	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	8.08e-05	0.00212	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP2C9—brain cancer	8.05e-05	0.00211	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.45e-05	0.00195	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—HES1—brain cancer	7.27e-05	0.0019	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—BSG—brain cancer	6.84e-05	0.00179	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	6.31e-05	0.00166	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—IDH1—brain cancer	5.88e-05	0.00154	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.86e-05	0.00154	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—CDK4—brain cancer	5.7e-05	0.00149	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.69e-05	0.00149	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.4e-05	0.00142	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—DNMT1—brain cancer	5.33e-05	0.0014	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.23e-05	0.00137	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—TP53—brain cancer	4.98e-05	0.0013	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.83e-05	0.00127	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.79e-05	0.00126	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—ESR2—brain cancer	4.79e-05	0.00125	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ENO2—brain cancer	4.65e-05	0.00122	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP2C9—brain cancer	4.54e-05	0.00119	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—NOTCH2—brain cancer	4.53e-05	0.00119	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.45e-05	0.00117	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.35e-05	0.00114	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.35e-05	0.00114	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.28e-05	0.00112	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—RELA—brain cancer	4.19e-05	0.0011	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—ERBB2—brain cancer	4.16e-05	0.00109	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.07e-05	0.00107	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—BSG—brain cancer	3.86e-05	0.00101	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—SIRT1—brain cancer	3.85e-05	0.00101	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.82e-05	0.001	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—CTNNB1—brain cancer	3.64e-05	0.000955	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.49e-05	0.000914	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—IDH1—brain cancer	3.32e-05	0.00087	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—VEGFA—brain cancer	3.21e-05	0.000841	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—STAT3—brain cancer	3.18e-05	0.000833	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—MYC—brain cancer	3.14e-05	0.000822	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.98e-05	0.000781	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—EGFR—brain cancer	2.89e-05	0.000757	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.7e-05	0.000709	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ENO2—brain cancer	2.62e-05	0.000688	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP2C9—brain cancer	2.61e-05	0.000684	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP2C9—brain cancer	2.33e-05	0.00061	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—BSG—brain cancer	2.22e-05	0.000582	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CG—brain cancer	2.13e-05	0.000559	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—BSG—brain cancer	1.98e-05	0.000519	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—IDH1—brain cancer	1.91e-05	0.0005	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP2C9—brain cancer	1.81e-05	0.000476	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—BSG—brain cancer	1.81e-05	0.000473	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—IDH1—brain cancer	1.7e-05	0.000446	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.55e-05	0.000407	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—IDH1—brain cancer	1.55e-05	0.000407	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—BSG—brain cancer	1.54e-05	0.000404	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MYC—brain cancer	1.51e-05	0.000396	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ENO2—brain cancer	1.51e-05	0.000395	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP2C9—brain cancer	1.4e-05	0.000367	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.39e-05	0.000363	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ENO2—brain cancer	1.35e-05	0.000353	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—IDH1—brain cancer	1.33e-05	0.000348	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.26e-05	0.000331	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ENO2—brain cancer	1.23e-05	0.000322	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CG—brain cancer	1.2e-05	0.000316	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—BSG—brain cancer	1.19e-05	0.000312	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.08e-05	0.000283	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ENO2—brain cancer	1.05e-05	0.000275	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—IDH1—brain cancer	1.02e-05	0.000268	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ENO2—brain cancer	8.09e-06	0.000212	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CG—brain cancer	6.92e-06	0.000181	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CG—brain cancer	6.17e-06	0.000162	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CG—brain cancer	5.63e-06	0.000148	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CG—brain cancer	4.81e-06	0.000126	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CG—brain cancer	3.71e-06	9.73e-05	CbGpPWpGaD
